---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-23-001558"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2023-12-01T23:59:59+00:00"
generated_at: "2026-06-07T19:16:30.753523+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lipella believes it meets Nasdaq minimum equity rule after $2M private placement

## Summary
- Private placement closed Oct 25, 2023; gross proceeds $2.0M, net ~$1.7M.
- Stockholders' equity as-adjusted: ~$3.9M (Sep 30, 2023) and ~$3.8M (Oct 31, 2023), above $2.5M minimum.
- Nasdaq will continue to monitor ongoing compliance; no assurance of future compliance.
- Previously disclosed Nasdaq delinquency notice on Nov 21, 2023 for minimum equity rule.
- Pre-funded warrants issued at $1.519/unit; exercise $0.001 per share; common warrants $1.40, 3-year term.

## SEC filing metadata
- accession: 0001753926-23-001558
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2023-12-01T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392623001558/0001753926-23-001558-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392623001558/g083874_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-23-001558
- JSON: https://secwatch.observer/filing/0001753926-23-001558.json
- Plain text: https://secwatch.observer/filing/0001753926-23-001558.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.